NFKB1 and cancer: Ganoderma lucidum polysaccharides have recently been exploited as potential components in the treatment of cancer, which induce the differentiation of MDSCs and inhibit their accumulation by activating the CARD9-NF-κB-IDO pathway in Lewis lung cancer, thereby preventing cancer progression (Wang et al., 2020).